BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 33086969)

  • 1. Diffuse alveolar haemorrhage in a case with anti-RNA polymerase III antibody-positive systemic sclerosis successfully treated with plasma exchange and corticosteroid therapy.
    Asai A; Banno S; Asai N; Ito M; Sugiyama H; Yamaguchi M; Iwagaitsu S; Nobata H; Kinasi H; Katsuno T; Ito Y
    Mod Rheumatol Case Rep; 2020 Jan; 4(1):51-55. PubMed ID: 33086969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical clinical presentation of a subset of patients with anti-RNA polymerase III--non-scleroderma cases associated with dominant RNA polymerase I reactivity and nucleolar staining.
    Ceribelli A; Krzyszczak ME; Li Y; Ross SJ; Chan JY; Chan EK; Burlingame RW; Webb TT; Bubb MR; Sobel ES; Reeves WH; Satoh M
    Arthritis Res Ther; 2011 Jul; 13(4):R119. PubMed ID: 21781293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case of renal crisis in a Korean scleroderma patient with anti-RNA polymerase I and III antibodies.
    Kang EH; Im CH; Kim SH; Chung JR; Lee EY; Kim DJ; Lee EB; Song YW
    J Korean Med Sci; 2006 Dec; 21(6):1121-3. PubMed ID: 17179700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary-renal syndrome in systemic sclerosis: a report of three cases and review of the literature.
    Naniwa T; Banno S; Sugiura Y; Yokota K; Oosawa T; Maeda S; Hayami Y; Takahashi N; Ueda R; Matsumoto Y
    Mod Rheumatol; 2007; 17(1):37-44. PubMed ID: 17278021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-RNA polymerase III antibody-associated scleroderma renal crisis in a patient with limited cutaneous systemic sclerosis: A case report.
    Takada D; Hoshino J; Kikuchi K; Yabuuchi J; Kogure Y; Ueno T; Sekine A; Yamanouchi M; Sumida K; Mise K; Suwabe T; Hayami N; Sawa N; Takaichi K; Hayasi N; Fujii T; Ohashi K; Ubara Y
    Mod Rheumatol; 2018 Mar; 28(2):369-372. PubMed ID: 26942857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.
    Nikpour M; Hissaria P; Byron J; Sahhar J; Micallef M; Paspaliaris W; Roddy J; Nash P; Sturgess A; Proudman S; Stevens W
    Arthritis Res Ther; 2011; 13(6):R211. PubMed ID: 22189167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-RNA polymerase III antibody prevalence and associated clinical manifestations in a large series of French patients with systemic sclerosis: a cross-sectional study.
    Meyer O; De Chaisemartin L; Nicaise-Roland P; Cabane J; Tubach F; Dieude P; Hayem G; Palazzo E; Chollet-Martin S; Kahan A; Allanore Y
    J Rheumatol; 2010 Jan; 37(1):125-30. PubMed ID: 19918031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and immunologic predictors of scleroderma renal crisis in Japanese systemic sclerosis patients with anti-RNA polymerase III autoantibodies.
    Hamaguchi Y; Kodera M; Matsushita T; Hasegawa M; Inaba Y; Usuda T; Kuwana M; Takehara K; Fujimoto M
    Arthritis Rheumatol; 2015 Apr; 67(4):1045-52. PubMed ID: 25512203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Demographic and clinical features of systemic sclerosis patients with anti-RNA polymerase III antibodies.
    Motegi S; Toki S; Yamada K; Uchiyama A; Ishikawa O
    J Dermatol; 2015 Feb; 42(2):189-92. PubMed ID: 25483258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiopulmonary Disease Development in Anti-RNA Polymerase III-positive Systemic Sclerosis: Comparative Analyses from an Unselected, Prospective Patient Cohort.
    Hoffmann-Vold AM; Midtvedt Ø; Tennøe AH; Garen T; Lund MB; Aaløkken TM; Andreassen AK; Elhage F; Brunborg C; Taraldsrud E; Molberg Ø
    J Rheumatol; 2017 Apr; 44(4):459-465. PubMed ID: 28089974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to RNA polymerase III in systemic sclerosis detected by ELISA.
    Santiago M; Baron M; Hudson M; Burlingame RW; Fritzler MJ
    J Rheumatol; 2007 Jul; 34(7):1528-34. PubMed ID: 17610318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features of systemic sclerosis patients with anti-RNA polymerase III antibody in a single centre in Spain.
    Callejas-Moraga EL; Guillén-Del-Castillo A; Marín-Sánchez AM; Roca-Herrera M; Balada E; Tolosa-Vilella C; Fonollosa-Pla V; Simeón-Aznar CP
    Clin Exp Rheumatol; 2019; 37 Suppl 119(4):41-48. PubMed ID: 30767873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diffuse alveolar haemorrhage associated with progressive systemic sclerosis.
    Griffin MT; Robb JD; Martin JR
    Thorax; 1990 Nov; 45(11):903-4. PubMed ID: 2256025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-RNA polymerase III antibodies in the diagnosis of scleroderma renal crisis sine scleroderma.
    Phan TG; Cass A; Gillin A; Trew P; Fertig N; Sturgess A
    J Rheumatol; 1999 Nov; 26(11):2489-92. PubMed ID: 10555916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of diffuse alveolar hemorrhage associated with interstitial pneumonia and systemic sclerosis].
    Toyoshima M; Chida K; Enomoto N; Nakamura Y; Imokawa S; Suda T
    Nihon Kokyuki Gakkai Zasshi; 2005 Jul; 43(7):437-41. PubMed ID: 16050472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-RNA polymerase III antibodies in the diagnosis of scleroderma renal crisis in the absence of skin disease.
    Bhavsar SV; Carmona R
    J Clin Rheumatol; 2014 Oct; 20(7):379-82. PubMed ID: 25275766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A fulminant case of systemic sclerosis/dermatomyositis complicating thrombotic microangiopathy and diffuse alveolar hemorrhage].
    Shoda T; Kotani T; Takeuchi T; Makino S; Hanafusa T
    Nihon Kokyuki Gakkai Zasshi; 2009 Mar; 47(3):227-31. PubMed ID: 19348271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of systemic sclerosis].
    Taieb D; Chauveau S; Khamis W; de Montmollin N; Sesé L; Duchemann B; Nunes H; Uzunhan Y
    Rev Mal Respir; 2020 Apr; 37(4):341-345. PubMed ID: 32284205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleolar staining cannot be used as a screening test for the scleroderma marker anti-RNA polymerase I/III antibodies.
    Yamasaki Y; Honkanen-Scott M; Hernandez L; Ikeda K; Barker T; Bubb MR; Narain S; Richards HB; Chan EK; Reeves WH; Satoh M
    Arthritis Rheum; 2006 Sep; 54(9):3051-6. PubMed ID: 16948135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of anti-RNA polymerase III antibodies in Chinese Han systemic sclerosis patients.
    Liu C; Hou Y; Xu D; Li L; Zhang Y; Cheng L; Yan S; Zhang F; Li Y
    Clin Rheumatol; 2020 Apr; 39(4):1191-1197. PubMed ID: 31858335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.